Publication | Closed Access

Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS)

HepatologyViral HepatitisAntiviral Drug DevelopmentHcv Genotype 1HepatitisVirologyAntiviral TherapyPharmacotherapyLiver DiseaseAntiviral DrugMedicinePrevious Protease-inhibitor Therapy